Valerie Pierce - Mar 3, 2022 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
SVP, GC & CCO
Signature
/s/ Valerie Pierce
Stock symbol
NGM
Transactions as of
Mar 3, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 03:08 PM
Next filing
Mar 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGM Stock Option (Right to Buy) Award $0 +150K $0.00 150K Mar 3, 2022 Common Stock 150K $15.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis.